[Primary coenzyme Q10 deficiency-7: a case report and literature review]

X R Chen1, J P Xu1, Y H Yao1

  • 1Department of Pediatrics, the First Affiliated Hospital of Xiamen University, Pediatric Key Laboratory of Xiamen, Institute of Pediatrics, School of Medicine, Xiamen University, Xiamen 361003, China.

Insights

Primary coenzyme Q10 deficiency-7 (COQ10D7) in children is characterized by respiratory distress, epilepsy, and cardiomyopathy, often linked to COQ4 gene variations. The c.370G>A mutation may be prevalent in Southern China.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Primary coenzyme Q10 deficiency (COQ10D) is a group of inherited metabolic disorders.
  • COQ10D7 specifically involves mutations in genes crucial for CoQ10 biosynthesis.
  • Understanding genetic variations in COQ4 is key to diagnosing and managing COQ10D7.

Observation:

  • A 5-month-old boy presented with epilepsy, growth retardation, hypotonia, and elevated lactic acid.
  • Genetic testing revealed a homozygous COQ4 gene variation (c.370G>A).
  • Analysis of 33 cases identified common phenotypes: neonatal respiratory distress, seizures, hypertrophic cardiomyopathy, and lactic acidosis.

Findings:

  • The COQ4 gene variation c.370G>A was identified as a potential hotspot in Southern Chinese children.
  • Diverse COQ4 gene variations (missense, frameshift, splicing, nonsense, deletion) cause COQ10D7.
  • Most patients exhibited severe neurological and cardiac manifestations, with a high mortality rate.

Implications:

  • Early identification of COQ10D7 phenotypes like respiratory distress and seizures is crucial.
  • Genetic testing for COQ4 gene variations aids in diagnosing primary coenzyme Q10 deficiency.
  • This study highlights the clinical spectrum and genetic basis of COQ10D7, informing prognosis and potential therapeutic strategies.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.0K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
585
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
786
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
848
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
470
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
695